Skip to content
Riskpilot
← Back to search
Sign in
Get full access
GLAXOSMITHKLINE PHARMA A/S
A/S
Active
CVR 27394019
Delta Park 37, 2665
Vallensbæk Strand
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1968 · 57 years old
84 employees
https://www.gsk.com
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
GLAXOSMITHKLINE PHARMA A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
158M
315M
473M
630M
442M
2020
446M
2021
440M
2022
474M
2023
548M
2024
EBITDA
DKK millions
21M
13M
4M
-5M
-14M
15M
2020
-11M
-173%
2021
16M
+245%
2022
16M
0%
2023
17M
+6%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
441.702
445.873
440.283
474.477
548.470
Staff expenses
-0
-0
-103.410
-103.673
-117.575
EBITDA
14.630
-11.001
15.851
16.108
16.959
Depreciation & amort.
-0
-0
-1.851
-364
-364
EBIT
14.630
-11.001
14.000
15.744
16.595
Net financials
-79
37
10
-281
-330
Profit before tax
14.551
14.309
14.341
15.463
16.265
Tax
2.280
5.325
3.273
3.460
4.025
Net profit
12.271
8.984
11.068
12.003
12.240
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
160.064
137.489
115.803
117.324
99.094
Equity
37.794
34.778
36.946
37.889
38.129
Long-term debt
0
0
0
0
0
Short-term debt
121.292
102.026
78.647
79.435
60.965
Total debt
121.292
102.026
78.647
79.435
60.965
Financial ratios
5-year trend
EBITDA margin
3.1%
This company
15.8%
Market median
-80% vs market
2020
2024
Equity ratio
38.5%
This company
38.2%
Market median
+1% vs market
2020
2024
Return on equity
32.1%
This company
18.4%
Market median
+74% vs market
2020
2024
Net profit margin
2.2%
This company
8.1%
Market median
-73% vs market
2020
2024
Asset turnover
5.53×
This company
1.12×
Market median
+394% vs market
2020
2024
Debt / equity
1.60×
This company
0.62×
Market median
-158% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on GLAXOSMITHKLINE PHARMA A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
